“…Further, since Na V iPA1 acts on all of the neuronal TTX-S Na V channels, this approach might be used to treat other excitability disorders, for example epilepsy. It remains to be seen whether a clinical version of the Na V iPA1 will prove to be an effective analgesic in humans, especially if it avoids adverse autonomic and motor effects, but the Shin et al ( 27 ) preclinical studies provide a first step.…”